After unveiling first-quarter financial results that exceeded industry watchers' forecasts and boosting its full-year revenue guidance, insulin pump maker Insulet (NASDAQ:PODD) saw its shares soaring 10% at 11 a.m. EDT Friday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,